BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9951496)

  • 41. The relation between intraocular pressure peak in the water drinking test and visual field progression in glaucoma.
    Susanna R; Vessani RM; Sakata L; Zacarias LC; Hatanaka M
    Br J Ophthalmol; 2005 Oct; 89(10):1298-301. PubMed ID: 16170120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship of progression of visual field damage to postural changes in intraocular pressure in patients with normal-tension glaucoma.
    Kiuchi T; Motoyama Y; Oshika T
    Ophthalmology; 2006 Dec; 113(12):2150-5. PubMed ID: 16996611
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monitoring glaucomatous visual field progression: the effect of a novel spatial filter.
    Strouthidis NG; Scott A; Viswanathan AC; Crabb DP; Garway-Heath DF
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):251-7. PubMed ID: 17197540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Frequency-doubling perimetry: comparison with standard automated perimetry to detect glaucoma.
    Leeprechanon N; Giangiacomo A; Fontana H; Hoffman D; Caprioli J
    Am J Ophthalmol; 2007 Feb; 143(2):263-271. PubMed ID: 17178091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progression of visual field loss in untreated glaucoma patients and suspects in St Lucia, West Indies.
    Wilson MR
    Trans Am Ophthalmol Soc; 2002; 100():365-410. PubMed ID: 12545702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advanced Glaucoma Intervention Study. 2. Visual field test scoring and reliability.
    Ophthalmology; 1994 Aug; 101(8):1445-55. PubMed ID: 7741836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The collaborative initial glaucoma treatment study: baseline visual field and test-retest variability.
    Gillespie BW; Musch DC; Guire KE; Mills RP; Lichter PR; Janz NK; Wren PA;
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2613-20. PubMed ID: 12766064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An Artificial Intelligence Approach to Detect Visual Field Progression in Glaucoma Based on Spatial Pattern Analysis.
    Wang M; Shen LQ; Pasquale LR; Petrakos P; Formica S; Boland MV; Wellik SR; De Moraes CG; Myers JS; Saeedi O; Wang H; Baniasadi N; Li D; Tichelaar J; Bex PJ; Elze T
    Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):365-375. PubMed ID: 30682206
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Visual field progression in patients with initially unilateral visual field loss from chronic open-angle glaucoma.
    Chen PP; Park RJ
    Ophthalmology; 2000 Sep; 107(9):1688-92. PubMed ID: 10964831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical implications of intra- and inter-reader agreement in four different automated visual fields.
    Alexander LJ; Corliss DA; Vinson C; Williams J; Casser L; Fingeret M; Malinovsky V; Townsend JC
    J Am Optom Assoc; 1995 Nov; 66(11):681-92. PubMed ID: 8576533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation of visual field progression between eyes in patients with open-angle glaucoma.
    Chen PP
    Ophthalmology; 2002 Nov; 109(11):2093-9. PubMed ID: 12414421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of methods to predict visual field progression in glaucoma.
    Nouri-Mahdavi K; Hoffman D; Ralli M; Caprioli J
    Arch Ophthalmol; 2007 Sep; 125(9):1176-81. PubMed ID: 17846355
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interobserver agreement and intraobserver reproducibility of the subjective determination of glaucomatous visual field progression.
    Tanna AP; Bandi JR; Budenz DL; Feuer WJ; Feldman RM; Herndon LW; Rhee DJ; Whiteside-de Vos J
    Ophthalmology; 2011 Jan; 118(1):60-5. PubMed ID: 20723992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A review of current technology used in evaluating visual function in glaucoma.
    Turalba AV; Grosskreutz C
    Semin Ophthalmol; 2010; 25(5-6):309-16. PubMed ID: 21091017
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of Long-Term Visual Field Function in Patients Undergoing Glaucoma Drainage Device Implantation.
    Liu Q; Saifee M; Yu Y; Ying GS; Li S; Zhong H; Gedde SJ; Han Y
    Am J Ophthalmol; 2020 Aug; 216():44-54. PubMed ID: 32224104
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patterns of visual field progression in patients with retinitis pigmentosa.
    Grover S; Fishman GA; Brown J
    Ophthalmology; 1998 Jun; 105(6):1069-75. PubMed ID: 9627658
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glaucoma monitoring in a clinical setting: glaucoma progression analysis vs nonparametric progression analysis in the Groningen Longitudinal Glaucoma Study.
    Wesselink C; Heeg GP; Jansonius NM
    Arch Ophthalmol; 2009 Mar; 127(3):270-4. PubMed ID: 19273789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estimating progression of visual field loss in glaucoma.
    Katz J; Gilbert D; Quigley HA; Sommer A
    Ophthalmology; 1997 Jun; 104(6):1017-25. PubMed ID: 9186444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Classifying visual field data.
    Hilton S; Katz J; Zeger S
    Stat Med; 1996 Jul; 15(13):1349-64. PubMed ID: 8841646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Visual field progression in glaucoma: estimating the overall significance of deterioration with permutation analyses of pointwise linear regression (PoPLR).
    O'Leary N; Chauhan BC; Artes PH
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6776-84. PubMed ID: 22952123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.